{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:21:27Z","timestamp":1792513287451,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T00:00:00Z","timestamp":1693094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T00:00:00Z","timestamp":1693094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004045","name":"Karadeniz Teknik \u00dcniversitesi","doi-asserted-by":"publisher","award":["TDK-2015-5340"],"award-info":[{"award-number":["TDK-2015-5340"]}],"id":[{"id":"10.13039\/501100004045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004045","name":"Karadeniz Teknik \u00dcniversitesi","doi-asserted-by":"publisher","award":["TDK-2015-5340"],"award-info":[{"award-number":["TDK-2015-5340"]}],"id":[{"id":"10.13039\/501100004045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004045","name":"Karadeniz Teknik \u00dcniversitesi","doi-asserted-by":"publisher","award":["TDK-2015-5340"],"award-info":[{"award-number":["TDK-2015-5340"]}],"id":[{"id":"10.13039\/501100004045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004045","name":"Karadeniz Teknik \u00dcniversitesi","doi-asserted-by":"publisher","award":["TDK-2015-5340"],"award-info":[{"award-number":["TDK-2015-5340"]}],"id":[{"id":"10.13039\/501100004045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004045","name":"Karadeniz Teknik \u00dcniversitesi","doi-asserted-by":"publisher","award":["TDK-2015-5340"],"award-info":[{"award-number":["TDK-2015-5340"]}],"id":[{"id":"10.13039\/501100004045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004045","name":"Karadeniz Teknik \u00dcniversitesi","doi-asserted-by":"publisher","award":["TDK-2015-5340"],"award-info":[{"award-number":["TDK-2015-5340"]}],"id":[{"id":"10.13039\/501100004045","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Protein J"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s10930-023-10145-1","type":"journal-article","created":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T09:01:56Z","timestamp":1693126916000},"page":"596-606","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Staphylococcus aureus Bacteriophage 52 Endolysin Exhibits Anti-Biofilm and Broad Antibacterial Activity Against Gram-Positive Bacteria"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6273-1536","authenticated-orcid":false,"given":"Mujib Abdulkadir","family":"Abdurahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9789-4738","authenticated-orcid":false,"given":"\u0130nci","family":"Durukan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5054-168X","authenticated-orcid":false,"given":"Tuba","family":"Din\u00e7er","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0497-6257","authenticated-orcid":false,"given":"Serap","family":"Pekta\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6848-7618","authenticated-orcid":false,"given":"Ersin","family":"Karata\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5506-0866","authenticated-orcid":false,"given":"Ali Osman","family":"Kili\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,27]]},"reference":[{"key":"10145_CR1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1128\/CMR.7.1.117","volume":"7","author":"WE Kloos","year":"1994","unstructured":"Kloos WE, Bannerman TL (1994) Update on clinical significance of coagulase-negative staphylococci. Clin Microbiol Rev 7:117\u2013140. https:\/\/doi.org\/10.1128\/CMR.7.1.117","journal-title":"Clin Microbiol Rev"},{"key":"10145_CR2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1086\/649797","volume":"31","author":"X Song","year":"2010","unstructured":"Song X, Perencevich E, Campos J, Short BL, Singh N (2010) Clinical and economic impact of methicillin-resistant Staphylococcus aureus colonization or infection on neonates in intensive care units. Infect Control Hosp Epidemiol 31:177\u2013182. https:\/\/doi.org\/10.1086\/649797","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10145_CR3","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1128\/AAC.45.3.649-659.2001","volume":"45","author":"A Sulakvelidze","year":"2001","unstructured":"Sulakvelidze A, Alavidze Z, Morris JG Jr (2001) Bacteriophage therapy. Antimicrob Agents Chemother 45:649\u2013659. https:\/\/doi.org\/10.1128\/AAC.45.3.649-659.2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10145_CR4","doi-asserted-by":"publisher","first-page":"699","DOI":"10.2174\/138920312804871193","volume":"13","author":"Z Drulis-Kawa","year":"2012","unstructured":"Drulis-Kawa Z, Majkowska-Skrobek G, Maciejewska B, Delattre AS, Lavigne R (2012) Learning from bacteriophages - advantages and limitations of phage and phage-encoded protein applications. Curr Protein Pept Sci 13:699\u2013722. https:\/\/doi.org\/10.2174\/138920312804871193","journal-title":"Curr Protein Pept Sci"},{"key":"10145_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2174\/138920110790725401","volume":"11","author":"E Kutter","year":"2010","unstructured":"Kutter E, De Vos D, Gvasalia G, Alavidze Z, Gogokhia L, Kuhl S, Abedon ST (2010) Phage therapy in clinical practice: treatment of human infections. Curr Pharm Biotechnol 11:69\u201386. https:\/\/doi.org\/10.2174\/138920110790725401","journal-title":"Curr Pharm Biotechnol"},{"key":"10145_CR6","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s10529-007-9346-1","volume":"29","author":"M Skurnik","year":"2007","unstructured":"Skurnik M, Pajunen M, Kiljunen S (2007) Biotechnological challenges of phage therapy. Biotechnol Lett 29:995\u20131003. https:\/\/doi.org\/10.1007\/s10529-007-9346-1","journal-title":"Biotechnol Lett"},{"key":"10145_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2174\/138920110790725410","volume":"11","author":"ST Abedon","year":"2010","unstructured":"Abedon ST, Thomas-Abedon C (2010) Phage therapy pharmacology. Curr Pharm Biotechnol 11:28\u201347. https:\/\/doi.org\/10.2174\/138920110790725410","journal-title":"Curr Pharm Biotechnol"},{"key":"10145_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ijmm.2005.09.002","volume":"296","author":"M Skurnik","year":"2006","unstructured":"Skurnik M, Strauch E (2006) Phage therapy: facts and fiction. Int J Med Microbiol 296:5\u201314. https:\/\/doi.org\/10.1016\/j.ijmm.2005.09.002","journal-title":"Int J Med Microbiol"},{"key":"10145_CR9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/B978-0-12-394438-2.00007-4","volume":"83","author":"DC Nelson","year":"2012","unstructured":"Nelson DC, Schmelcher M, Rodriguez-Rubio L, Klumpp J, Pritchard DG, Dong S, Donovan DM (2012) Endolysins as antimicrobials. Adv Virus Res 83:299\u2013365. https:\/\/doi.org\/10.1016\/B978-0-12-394438-2.00007-4","journal-title":"Adv Virus Res"},{"key":"10145_CR10","doi-asserted-by":"publisher","first-page":"7161","DOI":"10.1128\/JB.187.20.7161-7164.2005","volume":"187","author":"S O\u2019Flaherty","year":"2005","unstructured":"O\u2019Flaherty S, Coffey A, Meaney W, Fitzgerald GF, Ross RP (2005) The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus. J Bacteriol 187:7161\u20137164. https:\/\/doi.org\/10.1128\/JB.187.20.7161-7164.2005","journal-title":"J Bacteriol"},{"key":"10145_CR11","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.2217\/fmb.12.97","volume":"7","author":"M Schmelcher","year":"2012","unstructured":"Schmelcher M, Donovan DM, Loessner MJ (2012) Bacteriophage endolysins as novel antimicrobials. Future Microbiol 7:1147\u20131171. https:\/\/doi.org\/10.2217\/fmb.12.97","journal-title":"Future Microbiol"},{"key":"10145_CR12","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.mib.2005.06.002","volume":"8","author":"MJ Loessner","year":"2005","unstructured":"Loessner MJ (2005) Bacteriophage endolysins\u2013current state of research and applications. Curr Opin Microbiol 8:480\u2013487. https:\/\/doi.org\/10.1016\/j.mib.2005.06.002","journal-title":"Curr Opin Microbiol"},{"key":"10145_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4161\/bbug.1.1.9818","volume":"1","author":"M Fenton","year":"2010","unstructured":"Fenton M, Ross P, McAuliffe O, O\u2019Mahony J, Coffey A (2010) Recombinant bacteriophage lysins as antibacterials. Bioeng Bugs 1:9\u201316. https:\/\/doi.org\/10.4161\/bbug.1.1.9818","journal-title":"Bioeng Bugs"},{"key":"10145_CR14","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1086\/521305","volume":"196","author":"M Rashel","year":"2007","unstructured":"Rashel M, Uchiyama J, Ujihara T, Uehara Y, Kuramoto S, Sugihara S, Yagyu K, Muraoka A, Sugai M, Hiramatsu K, Honke K, Matsuzaki S (2007) Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11. J Infect Dis 196:1237\u20131247. https:\/\/doi.org\/10.1086\/521305","journal-title":"J Infect Dis"},{"key":"10145_CR15","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1128\/AAC.49.3.1225-1228.2005","volume":"49","author":"S Djurkovic","year":"2005","unstructured":"Djurkovic S, Loeffler JM, Fischetti VA (2005) Synergistic killing of Streptococcus pneumoniae with the bacteriophage lytic enzyme Cpl-1 and penicillin or gentamicin depends on the level of penicillin resistance. Antimicrob Agents Chemother 49:1225\u20131228. https:\/\/doi.org\/10.1128\/AAC.49.3.1225-1228.2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10145_CR16","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1093\/infdis\/jit637","volume":"209","author":"R Schuch","year":"2014","unstructured":"Schuch R, Lee HM, Schneider BC, Sauve KL, Law C, Khan BK, Rotolo JA, Horiuchi Y, Couto DE, Raz A, Fischetti VA, Huang DB, Nowinski RC, Wittekind M (2014) Combination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus-induced murine bacteremia. J Infect Dis 209:1469\u20131478. https:\/\/doi.org\/10.1093\/infdis\/jit637","journal-title":"J Infect Dis"},{"key":"10145_CR17","doi-asserted-by":"publisher","first-page":"8475","DOI":"10.1007\/s00253-015-6579-0","volume":"99","author":"M Schmelcher","year":"2015","unstructured":"Schmelcher M, Powell AM, Camp MJ, Pohl CS, Donovan DM (2015) Synergistic streptococcal phage lambdaSA2 and B30 endolysins kill streptococci in cow milk and in a mouse model of mastitis. Appl Microbiol Biotechnol 99:8475\u20138486. https:\/\/doi.org\/10.1007\/s00253-015-6579-0","journal-title":"Appl Microbiol Biotechnol"},{"key":"10145_CR18","doi-asserted-by":"publisher","first-page":"02629","DOI":"10.1128\/AAC.02629-16","volume":"61","author":"SY Jun","year":"2017","unstructured":"Jun SY, Jang IJ, Yoon S, Jang K, Yu K-S, Cho JY, Seong M-W, Jung GM, Yoon SJ, Kang SH (2017) Pharmacokinetics and tolerance of the phage endolysin-based candidate drug SAL200 after a single intravenous administration among healthy volunteers. Antimicrob Agents Chemother 61:02629\u201302616. https:\/\/doi.org\/10.1128\/AAC.02629-16","journal-title":"Antimicrob Agents Chemother"},{"key":"10145_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000473872","volume":"9","author":"JEE Totte","year":"2017","unstructured":"Totte JEE, van Doorn MB, Pasmans S (2017) Successful treatment of chronic Staphylococcus aureus-related dermatoses with the Topical Endolysin Staphefekt SA.100: a report of 3 cases. Case Rep Dermatol 9:19\u201325. https:\/\/doi.org\/10.1159\/000473872","journal-title":"Case Rep Dermatol"},{"key":"10145_CR20","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1128\/AAC.00890-10","volume":"55","author":"M Pastagia","year":"2011","unstructured":"Pastagia M, Euler C, Chahales P, Fuentes-Duculan J, Krueger JG, Fischetti VA (2011) A novel chimeric lysin shows superiority to mupirocin for skin decolonization of methicillin-resistant and -sensitive Staphylococcus aureus strains. Antimicrob Agents Chemother 55:738\u2013744. https:\/\/doi.org\/10.1128\/AAC.00890-10","journal-title":"Antimicrob Agents Chemother"},{"key":"10145_CR21","doi-asserted-by":"publisher","first-page":"668430","DOI":"10.3389\/fcimb.2021.668430","volume":"11","author":"Y Lu","year":"2021","unstructured":"Lu Y, Wang Y, Wang J, Zhao Y, Zhong Q, Li G, Fu Z, Lu S (2021) Phage endolysin LysP108 showed Promising Antibacterial potential against Methicillin-resistant Staphylococcus aureus. Front Cell Infect Microbiol 11:668430. https:\/\/doi.org\/10.3389\/fcimb.2021.668430","journal-title":"Front Cell Infect Microbiol"},{"key":"10145_CR22","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1080\/08927014.2021.1887151","volume":"37","author":"JWP Kuiper","year":"2021","unstructured":"Kuiper JWP, Hogervorst JMA, Herpers BL, Bakker AD, Klein-Nulend J, Nolte PA, Krom BP (2021) The novel endolysin XZ.700 effectively treats MRSA biofilms in two biofilm models without showing toxicity on human bone cells in vitro. Biofouling 37:184\u2013193. https:\/\/doi.org\/10.1080\/08927014.2021.1887151","journal-title":"Biofouling"},{"key":"10145_CR23","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.3390\/antibiotics10111277","volume":"10","author":"MU Rahman","year":"2021","unstructured":"Rahman MU, Wang W, Sun Q, Shah JA, Li C, Sun Y, Li Y, Zhang B, Chen W, Wang S (2021) Endolysin, a Promising solution against Antimicrobial Resistance. Antibiot (Basel) 10:1277. https:\/\/doi.org\/10.3390\/antibiotics10111277","journal-title":"Antibiot (Basel)"},{"key":"10145_CR24","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3390\/v13020328","volume":"13","author":"A Carroll-Portillo","year":"2021","unstructured":"Carroll-Portillo A, Coffman CN, Varga MG, Alcock J, Singh SB, Lin HC (2021) Standard bacteriophage purification procedures cause loss in numbers and activity. Viruses 13:328. https:\/\/doi.org\/10.3390\/v13020328","journal-title":"Viruses"},{"key":"10145_CR25","doi-asserted-by":"publisher","first-page":"105844","DOI":"10.1016\/j.ijantimicag.2019.11.001","volume":"55","author":"VS Gondil","year":"2020","unstructured":"Gondil VS, Harjai K, Chhibber S (2020) Endolysins as emerging alternative therapeutic agents to counter drug-resistant infections. Int J Antimicrob Agents 55:105844. https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.11.001","journal-title":"Int J Antimicrob Agents"},{"key":"10145_CR26","doi-asserted-by":"publisher","first-page":"e107307","DOI":"10.1371\/journal.pone.0107307","volume":"9","author":"D Gutierrez","year":"2014","unstructured":"Gutierrez D, Ruas-Madiedo P, Martinez B, Rodriguez A, Garcia P (2014) Effective removal of staphylococcal biofilms by the endolysin LysH5. PLoS ONE 9:e107307. https:\/\/doi.org\/10.1371\/journal.pone.0107307","journal-title":"PLoS ONE"},{"key":"10145_CR27","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01923-17","author":"D Gutierrez","year":"2018","unstructured":"Gutierrez D, Fernandez L, Rodriguez A, Garcia P (2018) Kill Staphylococcus aureus? mBio 9. https:\/\/doi.org\/10.1128\/mBio.01923-17. Are Phage Lytic Proteins the Secret Weapon To10.1128\/mbio. 01923 \u2013 01917"},{"key":"10145_CR28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jgar.2014.05.001","volume":"2","author":"O Denis","year":"2014","unstructured":"Denis O, Nonhoff C, Dowzicky MJ (2014) Antimicrobial susceptibility among Gram-positive and Gram-negative isolates collected in Europe between 2004 and 2010. J Glob Antimicrob Resist 2:155\u2013161. https:\/\/doi.org\/10.1016\/j.jgar.2014.05.001","journal-title":"J Glob Antimicrob Resist"},{"key":"10145_CR29","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3934\/microbiol.2019.4.324","volume":"5","author":"M Polaska","year":"2019","unstructured":"Polaska M, Sokolowska B (2019) Bacteriophages-a new hope or a huge problem in the food industry. AIMS Microbiol 5:324\u2013346. https:\/\/doi.org\/10.3934\/microbiol.2019.4.324","journal-title":"AIMS Microbiol"},{"key":"10145_CR30","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/978-981-13-7709-9_11","volume":"1148","author":"D Dams","year":"2019","unstructured":"Dams D, Briers Y (2019) Enzybiotics: enzyme-based antibacterials as therapeutics. Adv Exp Med Biol 1148:233\u2013253. https:\/\/doi.org\/10.1007\/978-981-13-7709-9_11","journal-title":"Adv Exp Med Biol"},{"key":"10145_CR31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.26444\/aaem\/105390","volume":"26","author":"T Mirski","year":"2019","unstructured":"Mirski T, Lidia M, Nakonieczna A, Gryko R (2019) Bacteriophages, phage endolysins and antimicrobial peptides - the possibilities for their common use to combat infections and in the design of new drugs. Ann Agric Environ Med 26:203\u2013209. https:\/\/doi.org\/10.26444\/aaem\/105390","journal-title":"Ann Agric Environ Med"},{"key":"10145_CR32","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00253-011-3104-y","volume":"90","author":"MJ Lai","year":"2011","unstructured":"Lai MJ, Lin NT, Hu A, Soo PC, Chen LK, Chen LH, Chang KC (2011) Antibacterial activity of Acinetobacter baumannii phage varphiAB2 endolysin (LysAB2) against both gram-positive and gram-negative bacteria. Appl Microbiol Biotechnol 90:529\u2013539. https:\/\/doi.org\/10.1007\/s00253-011-3104-y","journal-title":"Appl Microbiol Biotechnol"},{"key":"10145_CR33","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1574-6968.2012.02578.x","volume":"332","author":"J Park","year":"2012","unstructured":"Park J, Yun J, Lim JA, Kang DH, Ryu S (2012) Characterization of an endolysin, LysBPS13, from a Bacillus cereus bacteriophage. FEMS Microbiol Lett 332:76\u201383. https:\/\/doi.org\/10.1111\/j.1574-6968.2012.02578.x","journal-title":"FEMS Microbiol Lett"},{"key":"10145_CR34","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1128\/AAC.02526-12","volume":"57","author":"DB Gilmer","year":"2013","unstructured":"Gilmer DB, Schmitz JE, Euler CW, Fischetti VA (2013) Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 57:2743\u20132750. https:\/\/doi.org\/10.1128\/AAC.02526-12","journal-title":"Antimicrob Agents Chemother"},{"key":"10145_CR35","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3389\/fmicb.2015.01299","volume":"6","author":"H Dong","year":"2015","unstructured":"Dong H, Zhu C, Chen J, Ye X, Huang YP (2015) Antibacterial activity of Stenotrophomonas maltophilia Endolysin P28 against both Gram-positive and Gram-negative Bacteria. Front Microbiol 6:1299. https:\/\/doi.org\/10.3389\/fmicb.2015.01299","journal-title":"Front Microbiol"},{"key":"10145_CR36","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3390\/v12020192","volume":"12","author":"F Wang","year":"2020","unstructured":"Wang F, Ji X, Li Q, Zhang G, Peng J, Hai J, Zhang Y, Ci B, Li H, Xiong Y, Deng X, Lin L (2020) TSPphg Lysin from the Extremophilic Thermus Bacteriophage TSP4 as a potential Antimicrobial Agent against both gram-negative and gram-positive pathogenic Bacteria. Viruses 12:192. https:\/\/doi.org\/10.3390\/v12020192","journal-title":"Viruses"},{"key":"10145_CR37","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1574-6968.2008.01308.x","volume":"287","author":"SC Becker","year":"2008","unstructured":"Becker SC, Foster-Frey J, Donovan DM (2008) The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA. FEMS Microbiol Lett 287:185\u2013191. https:\/\/doi.org\/10.1111\/j.1574-6968.2008.01308.x","journal-title":"FEMS Microbiol Lett"},{"key":"10145_CR38","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1128\/IAI.71.11.6199-6204.2003","volume":"71","author":"JM Loeffler","year":"2003","unstructured":"Loeffler JM, Djurkovic S, Fischetti VA (2003) Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia. Infect Immun 71:6199\u20136204. https:\/\/doi.org\/10.1128\/IAI.71.11.6199-6204.2003","journal-title":"Infect Immun"},{"key":"10145_CR39","doi-asserted-by":"publisher","first-page":"18488","DOI":"10.3390\/ijms140918488","volume":"14","author":"M Chen","year":"2013","unstructured":"Chen M, Yu Q, Sun H (2013) Novel strategies for the prevention and treatment of biofilm related infections. Int J Mol Sci 14:18488\u201318501. https:\/\/doi.org\/10.3390\/ijms140918488","journal-title":"Int J Mol Sci"}],"container-title":["The Protein Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10930-023-10145-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10930-023-10145-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10930-023-10145-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T16:50:40Z","timestamp":1693932640000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10930-023-10145-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,27]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10145"],"URL":"https:\/\/doi.org\/10.1007\/s10930-023-10145-1","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"}]},"ISSN":["1572-3887","1875-8355"],"issn-type":[{"value":"1572-3887","type":"print"},{"value":"1875-8355","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,27]]},"assertion":[{"value":"31 July 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"The authors declare that there are no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}